<?xml version="1.0" encoding="UTF-8"?>
<p id="Par11">Childrenâ€™s consent-related vulnerability, coupled with the highly identifying nature of genomic data can accentuate ethical, legal and social issues (ELSI) of sharing such data [
 <xref ref-type="bibr" rid="CR6">6</xref>]. As computational capacities evolve to support more sophisticated geno/phenotypic analyses, so too must oversight bodies such as institutional review boards (IRB) [
 <xref ref-type="bibr" rid="CR7">7</xref>, 
 <xref ref-type="bibr" rid="CR8">8</xref>] and data access committees (DAC) be responsible for ensuring data protections are commensurate with anticipated benefits and realistic informational risks to children and their families [
 <xref ref-type="bibr" rid="CR9">9</xref>, 
 <xref ref-type="bibr" rid="CR10">10</xref>]. Recent studies suggest there is considerable debate on how data sharing benefits and risks should be interpreted, contextualized and communicated to prospective data contributors generally [
 <xref ref-type="bibr" rid="CR10">10</xref>], and when involving children specifically [
 <xref ref-type="bibr" rid="CR11">11</xref>, 
 <xref ref-type="bibr" rid="CR12">12</xref>].
</p>
